Yiling Pharmaceutical’s Patent Despair-resolving Drug Authorised for Promoting in China

&#13

&#13

&#13

BEIJING, Dec. 22, 2021 /PRNewswire/ — In accordance to Yiling Pharmaceutical’s recognize on Thursday (UTC+8), the Melancholy-resolving and Restlessness-relieving Capsules have been authorised for marketing and advertising through the attained Drug Registration Certificate issued by China’s Nationwide Medical Goods Administration (NMPA). The Corporation owns the complete intellectual assets rights of the drug.

&#13
&#13

The drug is an modern conventional Chinese medication (TCM) independently created by Yiling Pharmaceutical primarily based on scientific methods, applicable to moderate and reasonable despair with signs and symptoms of moodiness, dysphoria, reduction of appetite, sleeplessness and dreaminess, dizziness and tinnitus, and many others.

&#13
&#13

A multicenter, randomized, double-blind, double-simulated, placebo-fluoxetine hydrochloride pill controlled clinical trial has been conducted for the drug. The effects showed that: In accordance to the diminished values for principal efficacy indicators of the Hamilton Despair Scale (HAMD-17) scores from the baseline, the efficacy of the examination team was better than that of the placebo group, and also not inferior to that of the fluoxetine hydrochloride pill group with batter effectiveness in the scores for particular person TCM syndromes this kind of as mental despair, restlessness, insomnia and dreaminess, dizziness and tinnitus as properly as in Hamilton Stress and anxiety Scale (HAMA) scores.

&#13
&#13

It is documented that 11 new TCMs have been authorized in China this yr, a new large in current yrs, and the two innovative patent TCMs of “Despair-resolving and Restlessness-relieving Capsules” and “Kidney-tonifying and Heart-nourishing Tranquilization Tablets” produced by Yiling Pharmaceutical are in the record. Up to now, Yiling Pharmaceutical features 13 patent TCMs, masking cardiovascular and cerebrovascular conditions, respiratory health conditions, tumors, diabetes, nervous system health conditions, and so on., that includes exclusive item portfolios. In addition, the TCM of Lianhua Qingwen Capsules has become a leading brand for tackling colds, and Tongxinluo Capsules, Shensong Yangxin Capsules and Qiliqiangxin Capsules are the primary medications for treating cardiovascular and cerebrovascular ailments.

&#13
&#13

…